Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

by Takahashi Hiroki, Suga Moritaka, Kondoh Yasuhiro, Taniguchi Hiroyuki, Ebina Masahito, Ogura Takashi, Taguchi Yoshio, Azuma Arata, Nakata Koichiro, Sato Atsuhiko, Kudoh Shoji, Nukiwa Toshihiro
Published 2011-10-01

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

by Nakata Koichiro, Takahashi Hiroki, Suga Moritaka, Taguchi Yoshio, Ogura Takashi, Azuma Arata, Ebina Masahito, Kondoh Yasuhiro, Taniguchi Hiroyuki, Sato Atsuhiko, Sugiyama Yukihiko, Kudoh Shoji, Nukiwa Toshihiro
Published 2011-07-01